World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
25061
World Ranking
1737
National Ranking
854

Research.com Recognitions

  • 2008 - Fellow of the Indian National Academy of Engineering (INAE)

Overview

Michael R. Loken is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to subfields such as Hematology, Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, and Genetics.

The scientist's work covers a range of topics within hematologic malignancies and related therapies, including:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • CAR-T Cell Therapy Research
  • Hematopoietic Stem Cell Transplantation
  • Chronic Myeloid Leukemia Treatments
  • Multiple Myeloma Research and Treatments
  • Histone Deacetylase Inhibitors Research

Loken has published extensively on these topics, with frequent appearances in journals such as:

  • Blood
  • Cytometry Part B Clinical Cytometry
  • Blood Advances
  • Pediatric Blood & Cancer
  • Haematologica

Among Loken's recent papers are:

  • Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group, 2020, Haematologica
  • CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group, 2021, Blood
  • Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia, 2023, Haematologica
  • A longitudinal single-cell atlas of treatment response in pediatric AML, 2023, Cancer Cell
  • Cytokine-mediated CAR T therapy resistance in AML, 2024, Nature Medicine

They have collaborated frequently with other researchers, including:

  • Lisa Eidenschink Brodersen
  • Soheil Meshinchi
  • Laura Pardo
  • Todd A. Alonzo
  • E. Anders Kolb

Michael R. Loken was awarded the Fellow of the Indian National Academy of Engineering (INAE) in 2008.

Best Publications

  • Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

    D P Dialynas;Z S Quan;K A Wall;A Pierres

  • The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

    L. L. Lanier;An My Le;C. I. Civin;M. R. Loken

  • Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen‐Reactivity

    D. P. Dialynas;D. B. Wilde;P. Marrack;A. Pierres

  • Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.

    Leon W.M.M. Terstappen;Shiang Huang;Meredith Safford;Peter M. Lansdorp

  • Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development.

    Michael R. Loken;Virendra O. Shah;Virendra O. Shah;Karen L. Dattilio;Karen L. Dattilio;Curt I. Civin;Curt I. Civin

  • Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

    Richard A. Larson;Eric L. Sievers;Eric L. Sievers;Edward A. Stadtmauer;Bob Löwenberg

  • ANALYSIS OF CELL POPULATIONS WITH A FLUORESCENCE‐ACTIVATED CELL SORTER*

    Michael R. Loken;Leonard A. Herzenberg

  • Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

    Denise A. Wells;Martin Benesch;Michael R. Loken;Carlos Vallejo

  • Flow cytometric analysis of human bone marrow: I. Normal erythroid development

    Michael R. Loken;Michael R. Loken;Virendra O. Shah;Virendra O. Shah;Karen L. Dattilio;Karen L. Dattilio;Curt I. Civin;Curt I. Civin

  • Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry

    Michael R. Loken;Jeanne M. Brosnan;Bruce A. Bach;Kenneth A. Ault

  • A role for tumour necrosis factor-α, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

    Geoffrey M. Gersuk;Cassandra Beckham;Michael R. Loken;Peter Kiener

  • Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

    Michael R. Loken;Todd A. Alonzo;Todd A. Alonzo;Laura Pardo;Robert B. Gerbing

  • Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

    R A Larson;Marc Boogaerts;E Estey;C Karanes

  • Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry

    Leon W.M.M. Terstappen;Steen Johnsen;Ine M.J. Segers-Nolten;Michael R. Loken

  • Flow cytometry as an analytical and preparative tool in immunology.

    Michael R. Loken;Alan M. Stall

  • Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

    Arjan A. van de Loosdrecht;Canan Alhan;Marie Christine Béné;Matteo G. Della Porta

  • Flow cytometric analysis of human bone marrow. III. Neutrophil maturation.

    L. W. M. M Terstappen;M Safford;M. R Loken

  • Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow.

    C I Civin;M L Banquerigo;L C Strauss;M R Loken

  • Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia

    Mohamed L. Sorror;Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer

  • CD33 expression and P-glycoprotein–mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy

    Roland B. Walter;Roland B. Walter;Ted A. Gooley;Vincent H. J. van der Velden;Michael R. Loken

  • CD45 Gating for Routine Flow Cytometric Analysis of Human Bone Marrow Specimens

    Gregory T. Stelzer;Keith E. Shults;Michael R. Loken

Frequent Co-Authors

Todd A. Alonzo
Todd A. Alonzo University of Southern California
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
Betsy A. Hirsch
Betsy A. Hirsch University of Minnesota
Leon W.M.M. Terstappen
Leon W.M.M. Terstappen University of Twente
Irwin D. Bernstein
Irwin D. Bernstein Fred Hutchinson Cancer Research Center
Curt I. Civin
Curt I. Civin University of Maryland, Baltimore
Lillian Sung
Lillian Sung University of Toronto
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Frank W. Fitch
Frank W. Fitch University of Chicago
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring Immunology, related healthcare degrees offer valuable pathways to specialized careers. Many students interested in clinical and research roles consider nursing programs as a complementary option. For instance, online ABSN programs for non nurses provide a rapid route for individuals without a nursing background to transition into the nursing profession, blending foundational knowledge with hands-on skills.

When considering accelerated nursing options, the easiest accelerated nursing programs to get into can offer a smoother admission process, making it accessible to a broader range of applicants. These programs allow students to earn their degrees faster, which can be ideal for those eager to enter the workforce or pivot their career focus.

Entry-level nursing roles are also crucial in healthcare teams closely working with immunology patients. LPN programs with easiest admission requirements can be an excellent starting point for those seeking quick entry into the field while building practical experience that may lead to advanced study.

For those aiming to specialize further, the easiest FNP program (Family Nurse Practitioner) offers a streamlined path to advanced practice nursing. FNPs often work with immunocompromised patients, making this degree highly relevant in the immunology landscape.

Best Scientists Citing Michael R. Loken

Trending Scientists

Recently Published Articles